Goldman Sachs’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.18M | Buy |
161,786
+37,156
| +30% | +$1.18M | ﹤0.01% | 3489 |
|
|
2025
Q4 | $2.72M | Sell |
124,630
-38,822
| -24% | -$806K | ﹤0.01% | 4305 |
|
|
2025
Q3 | $3.51M | Buy |
163,452
+74,595
| +84% | +$1.67M | ﹤0.01% | 3968 |
|
|
2025
Q2 | $2.28M | Sell |
88,857
-35,849
| -29% | -$1.05M | ﹤0.01% | 4079 |
|
|
2025
Q1 | $4.56M | Buy |
124,706
+18,771
| +18% | +$646K | ﹤0.01% | 3453 |
|
|
2024
Q4 | $3.25M | Buy |
105,935
+32,388
| +44% | +$1.08M | ﹤0.01% | 3874 |
|
|
2024
Q3 | $2.77M | Buy |
73,547
+8,043
| +12% | +$310K | ﹤0.01% | 3854 |
|
|
2024
Q2 | $2.59M | Buy |
65,504
+35,409
| +118% | +$1.15M | ﹤0.01% | 3733 |
|
|
2024
Q1 | $1.01M | Sell |
30,095
-17,748
| -37% | -$597K | ﹤0.01% | 4345 |
|
|
2023
Q4 | $1.59M | Sell |
47,843
-74,517
| -61% | -$2.4M | ﹤0.01% | 4088 |
|
|
2023
Q3 | $3.84M | Buy |
122,360
+37,838
| +45% | +$1.19M | ﹤0.01% | 3219 |
|
|
2023
Q2 | $2.68M | Buy |
84,522
+15,019
| +22% | +$485K | ﹤0.01% | 3647 |
|
|
2023
Q1 | $2.3M | Buy |
69,503
+38,946
| +127% | +$1.28M | ﹤0.01% | 3755 |
|
|
2022
Q4 | $983K | Sell |
30,557
-87,395
| -74% | -$2.97M | ﹤0.01% | 4435 |
|
|
2022
Q3 | $4.21M | Buy |
117,952
+57,716
| +96% | +$2.4M | ﹤0.01% | 3277 |
|
|
2022
Q2 | $2.47M | Sell |
60,236
-7,247
| -11% | -$352K | ﹤0.01% | 3857 |
|
|
2022
Q1 | $3.91M | Buy |
67,483
+38,748
| +135% | +$2.12M | ﹤0.01% | 3583 |
|
|
2021
Q4 | $1.69M | Sell |
28,735
-16,697
| -37% | -$1.01M | ﹤0.01% | 4390 |
|
|
2021
Q3 | $2.76M | Buy |
45,432
+1,741
| +4% | +$102K | ﹤0.01% | 3899 |
|
|
2021
Q2 | $2.62M | Sell |
43,691
-634
| -1% | -$31.8K | ﹤0.01% | 3957 |
|
|
2021
Q1 | $2.09M | Buy |
44,325
+7,019
| +19% | +$289K | ﹤0.01% | 3930 |
|
|
2020
Q4 | $1.4M | Sell |
37,306
-6,237
| -14% | -$206K | ﹤0.01% | 3974 |
|
|
2020
Q3 | $1.42M | Sell |
43,543
-4,636
| -10% | -$196K | ﹤0.01% | 3816 |
|
|
2020
Q2 | $2.18M | Buy |
48,179
+33,742
| +234% | +$1.72M | ﹤0.01% | 3392 |
|
|
2020
Q1 | $659K | Sell |
14,437
-25,181
| -64% | -$1.14M | ﹤0.01% | 4040 |
|
|
2019
Q4 | $1.71M | Sell |
39,618
-24,397
| -38% | -$994K | ﹤0.01% | 3756 |
|
|
2019
Q3 | $2.32M | Buy |
64,015
+48,243
| +306% | +$2.03M | ﹤0.01% | 3434 |
|
|
2019
Q2 | $741K | Buy |
15,772
+2,582
| +20% | +$109K | ﹤0.01% | 4176 |
|
|
2019
Q1 | $464K | Buy |
+13,190
| New | +$518K | ﹤0.01% | 4449 |
|
|
2018
Q4 | – | Sell |
-6,135
| Closed | -$208K | – | 5223 |
|
|
2018
Q3 | $208K | Sell |
6,135
-4,550
| -43% | -$133K | ﹤0.01% | 4906 |
|
|
2018
Q2 | $267K | Sell |
10,685
-19,115
| -64% | -$532K | ﹤0.01% | 4847 |
|
|
2018
Q1 | $890K | Buy |
+29,800
| New | +$997K | ﹤0.01% | 4124 |
|
|
2017
Q1 | – | Sell |
-26,268
| Closed | -$592K | – | 6739 |
|
|
2016
Q4 | $592K | Buy |
+26,268
| New | +$634K | ﹤0.01% | 4908 |
|
|
2015
Q2 | – | Sell |
-6,900
| Closed | -$345K | – | 7246 |
|
|
2015
Q1 | $345K | Buy |
+6,900
| New | +$335K | ﹤0.01% | 5505 |
|
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
Goldman Sachs's ATEX Position: Q1 2026 in Review
Goldman Sachs increased its Anterix (ATEX) stake by 30% in Q1 2026, buying an estimated $1.18M and bringing the position to 161,786 shares worth $6.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3489.
Goldman Sachs first reported a position in ATEX in Q1 2015 and has held it in 34 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- Goldman Sachs held 161,786 shares of Anterix worth $6.18M as of Q1 2026.
- Goldman Sachs bought 37,156 Anterix shares in Q1 2026, an estimated $1.18M.
- Anterix made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3489 holding.
- Goldman Sachs first reported a position in Anterix in Q1 2015 and has held it in 34 quarters since.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.